Hidradenitis suppurativa
☆ Dina hasil Stiftung Warentest 2022 ti Jerman, kapuasan konsumen sareng ModelDerm ngan ukur langkung handap tibatan konsultasi telemedicine anu mayar.
Hidradenitis suppurativa (tahap I) dina kelek. Ieu mangrupikeun kasus anu hampang tina Hidradenitis suppurativa.
References
Hidradenitis suppurativa mangrupikeun kaayaan kulit anu kronis, terus datang deui, sareng tiasa mangaruhan sacara serius kahirupan anjeun. Éta disababkeun ku peradangan dina folikel rambut, sareng sering nyababkeun inféksi baktéri. Dokter biasana mendiagnosisna ku ningali jinis-jinis luka anjeun (sapertos nodul, bisul, atanapi saluran sinus) , dimana aranjeunna (biasana dina lipatan kulit) , sareng sabaraha sering aranjeunna datang deui sareng sabaraha lami aranjeunna tetep.
Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition. It is an inflammatory disorder of the follicular epithelium, but secondary bacterial infection can often occur. The diagnosis is made clinically based on typical lesions (nodules, abscesses, sinus tracts), locations (skin folds), and nature of relapses and chronicity.
Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition. It is an inflammatory disorder of the follicular epithelium, but secondary bacterial infection can often occur. The diagnosis is made clinically based on typical lesions (nodules, abscesses, sinus tracts), locations (skin folds), and nature of relapses and chronicity.
Pangobatan non-biologis sareng non-prosedur biasana dianggo nyalira pikeun panyakit anu hampang sareng tiasa digabungkeun sareng terapi biologis sareng bedah pikeun panyakit sedeng dugi ka parah. Studi panganyarna nyadiakeun bukti tambahan ngeunaan efektivitas pikeun ngagunakeun corticosteroids nyuntik langsung kana lesions pikeun HS flare-up jeung lesions localized. Saterusna, aya bukti suggesting yén maké tetracyclines nyalira bisa jadi sagampil éféktif salaku ngagabungkeun clindamycin jeung rifampicin.
Non-biologic and non-procedural treatments are often used as monotherapy for mild disease and can be used in conjunction with biologic therapy and surgery for moderate to severe disease. Recent studies highlighted in this review add support for the use of intralesional corticosteroids for HS flares and localized lesions, and there is evidence that monotherapy with tetracyclines may be as effective as the clindamycin/rifampicin combination.
Non-biologic and non-procedural treatments are often used as monotherapy for mild disease and can be used in conjunction with biologic therapy and surgery for moderate to severe disease. Recent studies highlighted in this review add support for the use of intralesional corticosteroids for HS flares and localized lesions, and there is evidence that monotherapy with tetracyclines may be as effective as the clindamycin/rifampicin combination.
Seueur pangobatan anu dianggo pikeun hidradenitis suppurativa, kalebet antibiotik, retinoid, antiandrogén, ubar anu ngahambat kekebalan, pangobatan anti radang, sareng radioterapi pikeun lesi awal. Pangobatan anu paling disarankeun nyaéta adalimumab sareng terapi laser. Bedah, boh éksisi saderhana atanapi éksisi lokal lengkep sareng grafting kulit, mangrupikeun pilihan anu langkung dipikaresep pikeun kasus parna, parah anu henteu ngaréspon ogé kana pangobatan anu sanés.
Many treatments are used for hidradenitis suppurativa, including antibiotics, retinoids, antiandrogens, immune-suppressing drugs, anti-inflammatory medications, and radiotherapy for early lesions. The top recommended treatments are adalimumab and laser therapy. Surgery, either simple excision or complete local excision with skin grafting, is the preferred option for severe, advanced cases that don't respond well to other treatments.
Many treatments are used for hidradenitis suppurativa, including antibiotics, retinoids, antiandrogens, immune-suppressing drugs, anti-inflammatory medications, and radiotherapy for early lesions. The top recommended treatments are adalimumab and laser therapy. Surgery, either simple excision or complete local excision with skin grafting, is the preferred option for severe, advanced cases that don't respond well to other treatments.
Anu ngabalukarkeun pasti biasana can écés, tapi dipercaya ngalibetkeun kombinasi faktor genetik jeung lingkungan. Sakitar sapertilu jalma anu kaserang panyakit ngagaduhan anggota kulawarga anu kapangaruhan. Faktor résiko sanésna kalebet obesitas sareng ngaroko. Kaayaan éta henteu disababkeun ku inféksi, kabersihan anu goréng.
Teu aya ubarna. Motong muka lesions pikeun ngidinan ka solokan teu ngahasilkeun kauntungan signifikan. Bari antibiotik anu ilahar dipaké, bukti pamakéan maranéhanana goréng. Pangobatan immunosuppressive ogé tiasa dicoba. Dina jalma anu ngagaduhan panyakit anu langkung parah, terapi laser atanapi bedah pikeun ngaleungitkeun kulit anu kapangaruhan tiasa giat. Jarang, lesi kulit tiasa janten kanker kulit.
Upami kasus hampang hidradenitis suppurativa kalebet, maka perkiraan frekuensina tina 1-4% tina populasi. Awéwé téh tilu kali leuwih gampang jadi didiagnosis kalawan eta ti lalaki. Awalna biasana dina dewasa ngora.